Copyright © 2008 Raghunath B. Toche et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
A novel method was successfully demonstrated towards the synthesis of
pyrido[1,2-a]pyrimidines having chloroethyl as an
intractable side chain, through dihydrofuranone intermediates. The dihydrofuranone intermediates
were synthesized by condensation of 2-aminopyridines with
α-acetyl-γ-butyrolactone, which upon cyclization using phosphorus
oxychloride or ethanol in sodium ethoxide furnished the
pyrido[1,2-a]pyrimidines in good yield.
1. Introduction
Heterofused pyrimidines exhibit promising antiviral
[1], antibacterial [2],
anti-AIDS [3], and antinociceptive [4] activities. Fused pyrimidines are
extensively used in neurology, particularly
in the treatment of
neurodegenerative disorders such as Parkinson’s disease [5], antianxiety
disorders [6], and depression [7]. Fused pyrimidines are selective inhibitors
for multidrug resistance (MDR) [8]. Folate metabolism has long been recognized
as an attractive target for cancer chemotherapy because of indispensable role
of
fused pyrimidines’ antifolates as antitumor agents [9].
Resperdone is a derivative of pyrido[1, 2-a]pyrimidines[10, 11].
These compounds showed
antipsychotic activity
[12] were used as 2 antagonists
[13–15]. They exhibits high affinity for 2-adrenoceptor with
high selectivity versus the -receptor and possesses potent in vivo
central activity
[16, 17],
Wamhoff and Korte [18, 19] have
reported the synthesis of pyrido[1,2-a]pyrimidines by using
2-aminoheterocylic compounds and α-acetyl-γ-butyrolactone by refluxing dioxane or using
PPA, and observed the formation of mixture of products. After the successful
study of the reactions of α-formy-γ-butyrolactone with 2-aminoheterocyles
[20],
our interest was sparked to synthesize old compounds by new method with improved yields.
2. Results and Discussion
In the present communication, we have developed new
methodology towards the synthesis of pyrido[1,2-a]pyrimidines with
3-hydroxy or 3-chloroethyl side chain.
Our method gives single product with high yield. Thus, 2-aminopyridines 1 and α-acetyl-γ-butyrolactone 2 were refluxed in toluene in presence of catalytic amount of PTSA using
Dean-Stark apparatus
(furnished dihydrofuran-2(3H)-one intermediate 3)
in 80–85% yield. Here,
PTSA is selective catalyst for protonation of carbonyl carbon to make NH2 attack more favorable. In presence of other acid catalysts such as conc. HCl,
conc. yields mixture of products as these acids also
protonated the ester carbonyl. The structure of furanone 3 was
characterized by spectral and analytical methods.
The IR of 3a showed the bands at 3200 and for NH and lactone CO stretching frequencies;
the lactone carbonyl frequency lowered by 30–40 due to hydrogen bonding between CO and NH
groups. The 1H NMR of 3a showed two triplets at δ2.92 and
4.31 for – and – protons, respectively, with Hz. The singlet appeared at for CH3 protons as it is attached to olefinic carbon.
The broad
singlet appeared at corresponding to NH proton (exchangeable
with ). The NMR spectrum of this compound exhibits peaks at δ19.48, 26.26, 65.43, 93.62, 113.9, 117.51,
137.86, 147.83, 152.41, 153.52, and 173.72. Further, the structure of 3a was assigned by HMBC and COSY experiments, which is in agreement with the
structure proposed. We have also tried the above reactions in ammonium acetate
without using any solvent. Thus, 2-aminopyridine and α-acetyl-γ-butyrolactone were fused in ammonium acetate
at C, and the reaction mixture was stirred in water to remove
excess of ammonium acetate and unreacted pyridine if any to yield 4 in 56% yield. Interestingly, it was observed that in ammonium
acetate the 3-hydroxyethyl side chain gets acylated to yield 3-acetyl
derivative 4. The ammonium acetate worked as acetylating agent, and
reaction demonstrates green approach for the synthesis of pyrido[1,2-a]pyrimidines.
Similarly, the structure of compound 4 was characterized by spectral and analytical methods. The IR of 4 shows
peaks at 1670 (amide) and 1740 (ester) .
The 1H NMR spectrum of 4 showed two singlets at δ2 and
2.52 for and protons, and two triplets at δ3.03 and 4.27 for – and –
protons, respectively. The multiplet appeared
at δ7.07–8.90
corresponding to 4 aromatic protons. The NMR spectrum of this compound exhibits peaks at δ21.06,
22.72, 26.58, 62.59, 111.46, 114.98, 125.83, 127.06, 135.30, 148.79, 157.87,
162.62, and 171.06. Further, the structure of 4 was assigned by HMBC and
COSY experiments, which is in agreement with the structure proposed. The
compound 3 was cyclized to target
pyrido[1,2-a]pyrimidines 5 having 3-hydroxyethyl side chain by refluxing in weak or strong base like or NaOH, or was cyclized to 6 having 3-chloroethyl side chain by
refluxing in POCl3. These cyclized compounds 5 and 6 were
characterized by IR, NMR, and elemental analysis. Thus, in the IR spectrum of 5, the bands at 1690 and
3050 due to lactone and NH stretching in 3 disappeared, and new bands at 1670 and 3260 for OH and C=O groups were observed. The NMR showed the peaks at δ3.01 and 3.92 with Hz for – and – protons. The additional broad singlet that
appeared at
is due to
OH group.
The compound 3 or 5 when refluxed in to finish the pyridopyrimidines 6 having
3-chloroethyl side chain. These
compounds were characterized by comparing their mp and spectroscopic data with those
of literature-reported compounds [19]; further
the product was confirmed by
preparing its azido derivative 7,
with NaN3 in DMF,
which shows characteristic stretching frequency at 2100 for .
The elimination of terminal halide in 6 was carried out using strong base to yield pyrido[1,2-a]pyrimidine 8 with 3-ethylene side chain. Compound 8 shows IR stretching at 1630 for carbon-carbon double bond. Two doublets were
observed at δ5.63 with Hz and at δ6.55
with Hz for
two olefinic protons due to cis- and transcoupling. The =C–H proton appears as
triplet at 6.83 with and 8 Hz.
3. Conclusion
The work demonstrates the new methodology towards
the synthesis of pyrido[1,2-a]pyrimidines having intractable chloroethyl
side chain using cyclic β-ketoesters
and 2-aminopyridines. The new methods furnish improved yields up to 80–85% of
dihydrofuranone intermediate and 70–75% of cyclized
pure product.
4. Experimental
Melting points were determined in open capillary
tubes on a Gallenkamp melting point apparatus (Mod. MFB-595 in open capillary
tubes), and were uncorrected. Infrared spectra were recorded on a Perkin-Elmer
298 spectrophotometer in potassium bromide pellets unless otherwise stated. NMR spectra were recorded on a Varian Gemini 200 (200 MHz)
spectrometer. NMR spectra were recorded on a Buker AM 360 (90 MHz) spectrometer. The
chemical shifts are reported in δunits relative to internal standard
tetramethylsilane. Elemental analyses were performed on Fisons EA 1108 C,H,N-automatic
analyzer, and were within ±0.3 of the theoretical percentage. All reactions
were monitored by thin layer chromatography on 0.2 mm silica gel 60 (Merck, Mumbai, India) plates
using UV light (254 and 365 nm) for detection. All the reagents were used as
received from commercial sources. The solvents were dried over the 40 nm
molecular sieves.
4.1. General Procedure for the Synthesis of dihydrofuranone-2-(3H)-one (3a–3c)
The mixture of 2-aminopyridines 1 (10 mmol)
and α-acetyl γ-butyrolactone 2 (10 mmol, 1.28 g, or
1.10 mL) was refluxed in toluene (30 mL) for 24 hours in presence of catalytic
amount of PTSA (0.02 g). The water separator was attached between the reaction
flask and the water condenser. The separation of equivalent amount of water
indicates the completion of reaction. The solid obtained after cooling the
reaction mixture was filtered and washed with toluene and then recrystallized
in suitable solvent.
4.2. 3-[1-(Pyridin-2-ylamino)ethylidene]dihydrofuran 2(3H)-one
(3a, )
Yield 1.69 g (83%), mp 87-C (ligroin,
colorless flakes); IR: (KBr): 3200 (NH), ,
1690 (C=O lactone), 1640, 1600(C=C), 1570, 1500, 1480, 1410 ; NMR: ()
(s, 3H, ), 2.92 (, Hz, 2H, ), 4.31 (t, Hz, 2H, ), 6.75 (dd, & 8.1 Hz, 1H, –H), 6.83 (dt, & 8.3 Hz, 1H, –H), 8.75 (dt, & 8.3 Hz, 1H, –H), 8.25 (dd, & 8.3 Hz, 1H, –H), 10.5 (bs, 1H, NH) ppm. NMR (): 19.48 (), 26.26 (), 65.43 (), 93.62 (C=C), 113.99 (), 117.91 (); 137.86 (); 147.83 (); 153.22(); 173.72 (C=O) ppm.
4.3. 3-1-[(6-Methylpyridin-2-yl)amino]ethylidene dihydrofuran-2(3H)-one
(3b, )
Yield 1.74 g (80%), mp 105-C (cyclohexane,
colorless flakes); IR (KBr): 3200 (NH), 2920, 2860(w, ), 1690(C=O lactone), 1650(NH),
1600(C=C), 1580, 1560, 1480, 1430 ; NMR ():
(s, 3H, ), 3.95 (t, Hz, 2H, ), 4.42 (t, Hz, 2H, ), 6.63 (dd, & 2.8 Hz, 1H, –H), 7.45 (t, & 7.8 Hz, 1H, –H); 6.70 (d, & 2.9 Hz, 1H, –H); 10.55 (bs, 1H, NH) ppm.
4.4. 3-1-[(4-Methylpyridin-2-yl)amino]ethylidene dihydrofuran-2(3H)-one
(3c, )
Yield 1.85 g
(85%), mp 72-C
(cyclohexane, colorless flakes); IR (KBr): 3200 (b, NH), 2910, 2880(w, ), 1780 (s, C=O lactone), 1650 (s, NH),
1610, 1560, 1480, 1450, ; NMR () (s,
3H, ), 2.52 (s, 3H, ), 2.92 (t, Hz, 2H, ), 4.36 (t, Hz, 2H, ), 6.75 (s, 1H, –H), 6.75 (d, Hz, 1H, –H); 8.19 (d, Hz 1H, –H); 10.52 (bs, 1H, NH) ppm.
4.5. General Procedure for the Synthesis of
2-(2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl acetate ()
The mixture of 2-aminopyridine 1 (10 mmol)
and α-acetyl γ-butyrolactone 2 (10 mmol, 1.28 g, or
1.10 mL) was heated in ammonium acetate (0.05 mol, 3.85 g) at 100–C for 1-2 hours. The
reaction mixture was stirred in water, and extracted with chloroform. The
chloroform extract was dried over anhydrous sodium sulphate, and evaporated to
furnish a colorless solid, and the compounds were recrystallized in suitable
solvent.
Yield 1.37 g (56%), mp 121-C (ligroin,
colorless flakes); IR (KBr): 2980,
2880(w, ), 1740(s, C=O lactone), 1670(s, C=O),
1530, 1470, ; NMR (): δ= 2.00
(s, 3H, ), 2.52 (s, 3H, ), 3.03 (t, Hz, 2H, ), 4.27 (t, Hz, 2H, ), 7.07 (dt, Hz, 1H, –H), 7.56 (dd, Hz, 1H, –H); 7.63 (dt, Hz, 1H, –H); 8.90 (dd, Hz, 1H, –H) ppm. NMR (): 21.06 (), 22.72 (CH3), 26.58 (), 62.59 (), 111.46 (), 114.98 (), 125.83 (); 127.06 (); 135.30 (); 148.79 (); 157.87 (), 162.62 (C=O), 171.06 (C=O) ppm.
4.6. General Procedure for the Synthesis of
3-(2-hydroxyethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (5a, 5b)
4.6.1. Method A
The furanone 3 (10 mmol) was dissolved in ethanol (20 mL), and the solution was
refluxed with sodium ethoxide (0.23 g of freshly cut sodium metal was dissolved
in 10 mL of dry ethanol) for 1 hour. The solvent was removed under reduced
pressure. The residue was dissolved in cold water (100 mL) and extracted with
chloroform. The chloroform was dried over sodium sulfate and evaporated to
yield 5 in good yield.
4.6.2. Method B
The compound 4 (10 mmol) was refluxed in ethanol in presence of
catalytic amount of sodium hydroxide for about 3-4 hours
(TLC check). The excess of solvent was removed under reduced pressure, and the
obtained precipitate was dissolved in water and stirred for 1 hour. Then, it
was filtered, washed with water, dried, and recrystallized from proper solvent
to afford 5 in good yield.
4.7. 3-(2-hydroxyethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
(5a, )
Yield 1.42 g (70%), mp 158-C
(cyclohexane, colorless needles); IR (KBr): 3260 (b, OH), 2880 (w, ), 1670 (s, C=O lactone), 1640(s, NH),
1530, 1470, 1440, ; 1H NMR (): δ= 2.62
(s, 3H, ), 3.03 (t, Hz 2H, ), 3.96 (t, Hz, 2H, ), 7.17 (m, 1H, –H), 7.43 (bs, 1H, OH); 7.65 (d, Hz, 1H, –H); 7.77 (m, 1H, –H); 9.09 (d, Hz, 1H, –H) ppm.
4.8. 3-(2-hydroxyethyl)-2,6-dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one
(5b, )
Yield 1.54 g (71%), mp 175-C (ligroin,
colorless needles); IR (KBr): 3250 (b, OH), 2920, 2880(w, ), 1670 (s, C=O lactone), 1640, 1570,
1520,1470, ; NMR (): (s, 3H, ), 2.52 (s, 3H, ), 3.06 (t, Hz, 2H, ), 3.52 (s, 1H, OH), 3.92 (t, Hz, 2H, ), 6.96 (dd, Hz, 1H, –H), 7.22 (d, Hz, 1H, –H); 8.89 (d, Hz, 1H, –H) ppm.
4.9. General Procedure for the Synthesis of
3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (6a–6c)
Compound 3 or 5 (10 mmol) was
refluxed in phosphorus oxychloride (20 mL) for 1 hour (TLC check). After
completing the reaction, the excess of phosphorus oxychloride was removed under
reduced pressure. The residue obtained was stirred in ice-cold water (100 mL)
for 30 minutes, then neutralized with solid sodium carbonate and further
stirred overnight. The solid precipitated was filtered and washed with water
and recrystallized from suitable solvent.
4.10. 3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
(6a, )
Yield 1.60 g (72%), mp 140–C
(cyclohexane, colorless needles); IR (KBr): 2950 (w, ), 1670(s, C=O lactone), 1640, 1580,
1540, 1480, 1430 ; NMR (): (s, 3H, ); 3.23 (t, Hz, 2H, ), 3.88 (t, Hz, 2H, ), 7.15 (t, Hz 1H, –H), 7.69 (d, Hz 1H, –H); 7.78 (t, 1H, –H); 9.07 (d, 1H, –H) ppm.
4.11. 3-(2-chloroethyl)-2,6-dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one
(6b, )
Yield 1.65 g (70%), mp 113-C
(cyclohexane, colorless needles); IR (KBr): 2980 (w, ), 1670(s, C=O lactone), 1640, 1580,
1540, 1470, 1440 ; NMR (): (s, 3H, ); 3.09 (s, 3H, ); 3.18 (t, Hz, 2H, ), 3.87 (t, Hz, 2H, ), 7.38 (t, Hz, 1H, –H), 6.66 (d, Hz, 1H, –H) ppm.
4.12. 3-(2-chloroethyl)-2,8-dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one
(6c, )
Yield 1.77 g (75%), mp 116-C
(cyclohexane, colorless needles); IR (KBr):
1670 (s, C=O lactone), 1640, 1560, 1530, 1470, ; 1H NMR (); (s, 3H, ), 2.53 (s, 3H, ), 3.24 (t, Hz, 2H, ), 3.89 (t, Hz, 2H, ), 6.92 (d, Hz, 1H, –H), 8.96 (d, ,
1H, –H), 7.41 (d, Hz, 1H, –H) ppm.
4.13. General Procedure for the Synthesis of
3-(2-azidoethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one ()
To a stirred solution of 6 (10 mmol) in DMF/ (9:1), the sodium azide (2.60 g, 40 mmol) was
added and temperature was raised slowly to C. The mixture was
kept at this temperature for about 2 hours until TLC showed no more starting
material. The temperature was raised to C for 1 hour, and then
the solvent was removed under reduced pressure; an oily residue was poured in
ice-cold water and stirred for 1 hour; the solid obtained was filtered, washed
with water, dried, and recrystallized from the proper solvent to
afford 7 in good yield.
Yield 1.60 g (70%), mp 65-C
(cyclohexane, colorless solid); IR (KBr):
2980(w, ), 2100(), 1660(s, C=O lactone), 1640, 1560,
1530,1470, .
4.14. General Procedure for the Synthesis of
2-methyl-3-vinyl-4H-pyrido[1,2-a]pyrimidin-4-one
()
To a stirred
solution of 6 (10 mmol) in ethanol, the solution of sodium ethoxide (prepared by reacting 0.27 gms,
11.5 mg atoms of sodium in 50 mL of
absolute ethanol) was added. The reaction mixture was refluxed for about 10-11 hours. (TLC
check). Then, the excess of solvent was removed under reduced pressure, and
the obtained solid was filtered, washed with ethanol, dried, and recrystallized
from the proper solvent to afford 8 in good yield.
Yield 1.20 g (60%), mp 110-C
(cyclohexane, colorless solid) IR (KBr):
3020(w, ), 1670(s, C=O lactone), 1640, 1560,
1530, 1470, ; NMR (): (s, 3H, ); 5.63 & 6.55 (dd, Hz, 2H, = ); 6.83 (t, Hz, 1H, =C–H); 7.13 (dt, Hz, 1H, –H), 7.66 (dt, Hz, 1H, –H); 7.75 (dt, Hz, 1H, –H); 9.12 (dd, Hz, 1H, –H) ppm.
Table 1: Elemental analysis.
Acknowledgments
The authors would like to thank the University
Grants Commission, New Delhi, for financial
assistance under major research project, the Director of Advanced Instrument
Center, University of Punjab, Chandigarh,
and the University of Pune
for instrumental
facilities. They also thank the Principal
of KTHM College, Nashik-2 MS, India.
- N. Hossain, J. Rozenski, E. De Clercq, and P. Herdewijn, “Synthesis and antiviral activity of the -analogues of 1,5-anhydrohexitol nucleosides (1,5-anhydro-2,3-dideoxy-D-ribohexitol nucleosides),” Journal of Organic Chemistry, vol. 62, no. 8, pp. 2442–2447, 1997.
- R. W. Sabnis and D. W. Rangnekar, “Synthesis of thieno[2,3-d]pyrimidine derivatives and their
fluorescent and biological properties,” Indian Journal of Technology, vol. 28, no. 2, pp. 54–58, 1990.
- S. Joseph and J. M. Burke, “Optimization of an anti-HIV hairpin ribozyme by in vitro selection,” The Journal of Biological Chemistry, vol. 268, no. 33, pp. 24515–24518, 1993.
- B. C. Bookser, B. G. Ugarkar, M. C. Matelich, et al., “Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy--d-ribofuranosyl) pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds,” Journal of Medicinal Chemistry, vol. 48, no. 24, pp. 7808–7820, 2005.
- P. G. Baraldi, B. Cacciari, R. Romagnoli, et al., “7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility,” Journal of Medicinal Chemistry, vol. 45, no. 1, pp. 115–126, 2002.
- S. C. Goodacre, L. J. Street, D. J. Hallett, et al., “Imidazo[1,2-]pyrimidines as functionally selective and orally bioavailable 2/3 binding site agonists for the treatment of anxiety disorders,” Journal of Medicinal Chemistry, vol. 49, no. 1, pp. 35–38, 2006.
- C. Chen, K. M. Wilcoxen, C. Q. Huang, et al., “Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylamino-pyrazolo[1,5-]pyrimidine (NBI 30775/R121919) and structure-activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists,” Journal of Medicinal Chemistry, vol. 47, no. 19, pp. 4787–4798, 2004.
- S. Wang, A. Folkes, I. Chuckowree, et al., “Studies on pyrrolopyrimidines as selective Inhibitors of multidrug-resistance-associated protein in multidrug resistance,” Journal of Medicinal Chemistry, vol. 47, no. 6, pp. 1329–1338, 2004.
- A. Gangjee, H. D. Jain, J. Phan, et al., “Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates,” Journal of Medicinal Chemistry, vol. 49, no. 3, pp. 1055–1065, 2006.
- O. Bruno, C. Brullo, S. Schenone, et al., “Synthesis, antiplatelet and antithrombotic activities of new 2-substituted benzopyrano[4,3-d]pyrimidin-4-cycloamines and 4-amino/cycloamino-benzopyrano[4, 3-d]pyrimidin-5-ones,” Bioorganic & Medicinal Chemistry, vol. 14, no. 1, pp. 121–130, 2006.
- G. La Vielle, T. Dubuffet, O. Muller, M. Millan, A. Dekeyne, and M. Brocco, “Preparation of pyrimidin-4-one derivatives, their pharmaceutical compositions and use as 2/5-HT2c double antagonists,” (Les Laboratories Servier, France) FR 2823752 Al20021025, 2002.
- R. T. Venkatasubramanian, D. G. Sathe, D. Govind, and C. V. Suryavanshi, “A process for the preparation of antipschotic 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1
-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-]pyrimidin-4-one,” (RRG Life Sciences). Limited, India) PCT International Application WO 2001085731 A20011115, 2001.
- K. L. E. Josephine, P. S. M. Aloysius, and B. F. Paul, “Benzothieno[3,2-c]pyridines as 2 antagonists,” (Janssen Pharmaceutica N.V. Belg.) PCT International Application WO 2000020422 Al 20000413, 2000, Chemical Abstracts, 132, 265188t.
- K. L. E. Josehine, V. D. Keybus, F. M. Alfons, and M. J. Carolus, “Tricyclic g(d)3-piperidines as g(a)2-antagonists,” PCT International Application WO 2000020421 A2 200002413, 2000,
Chemical Abstracts, 132, 265187c.
- L. E. J. Kennis, F. P. Bischoff, C. J. Mertens, et al., “New 2-substituted 1,2,3,4-tetrahydrobenzofuro[3,2-c]pyridine having highly active and potent central -antagonistic activity as potential antidepressants,” Bioorganic & Medicinal Chemistry Letters, vol. 10, no. 1, pp. 71–74, 2000.
- K. L. E. Josephine, C. J. Love, and P. F. Bischoff, “1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives,” PCT International Application WO/1998/045297 Al 19981015, 1998,
Chemical Abstracts, 129, 302654c.
- C. J. Coulson, R. E. Ford, E. Hunt, et al., European Journal of Medicinal Chemistry, vol. 9, p. 13, 1974.
- H. Wamhoff and F. Korte, “The synthesis of heterocyclic compounds starting from lactones, lactams, and thiollactones,” Synthesis, vol. 1972, no. 4, pp. 151–175, 1972.
- H. J. Willenbrock, H. Wamhoff, and F. Korte, “Über Reactions des -Acetyl-γ-butyrolactones mit heterocyclishen Amines,” Justus Liebigs Annalen der Chemie, vol. 1, p. 103, 1973.
- R. B. Toche, B. K. Ghotekar, M. A. Kazi, D. B. Kendre, and M. N. Jachak, “Synthesis of fused pyrimidines from amines and cyclic -formylesters,” Tetrahedron, vol. 63, no. 34, pp. 8157–8163, 2007.